AtriCure (ATRC) vs UFP Technologies (UFPT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
AtriCure (ATRC) has outperformed UFP Technologies (UFPT) over the past year, gaining 50.6% versus a gain of 45.9%. Over five years, UFPT leads with a +349.0% price change compared with -26.0% for ATRC. AtriCure is the larger company by market cap ($2.80 billion vs $2.25 billion), about 1.2 times the size, while UFP Technologies is growing revenue faster (+19.5% vs +14.9%).
On valuation, UFP Technologies trades at a lower forward P/E (24.4x vs 126.8x for AtriCure). UFP Technologies converts more of its revenue into profit, with a net margin of 11.3% versus -2.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATRC | UFPT |
|---|---|---|
| Share price | $55.02 | $290.06 |
| Market cap | $2.80B | $2.25B |
| 1-day change | +4.12% | +1.22% |
| YTD return | +33.57% | +29.06% |
| 1-year return | +50.63% | +45.90% |
| 5-year return | -25.96% | +349.01% |
| P/E ratio (TTM) | 261.98 | 31.32 |
| Forward P/E | 126.77 | 24.43 |
| EPS (TTM) | $0.21 | $9.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $534.53M | $602.80M |
| Revenue growth (YoY) | +14.88% | +19.50% |
| Net income (latest FY) | $-11.45M | $68.31M |
| Gross margin | 74.98% | 28.27% |
| Operating margin | -1.77% | 15.32% |
| Net margin | -2.14% | 11.33% |
| 52-week high | $61.70 | $338.71 |
| 52-week low | $25.36 | $173.86 |
| Distance from 52-week high | -10.83% | -14.36% |
| Analyst consensus | buy | none |
| Avg. price target upside | -0.23% | +22.39% |
| Average volume | 1.08M | 154.12K |
| Shares outstanding | 50.87M | 7.75M |
| Employees | 1,350 | 4,846 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AtriCure trades at a higher earnings multiple (262.0x vs 31.3x trailing P/E).
- UFP Technologies is more profitable, keeping 11.3 cents of every revenue dollar as net income versus -2.1 cents for AtriCure.
About AtriCure
ATRC stock →AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.
Health Care · Medical/Dental Instruments · 1,350 employees
About UFP Technologies
UFPT stock →UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing.
Health Care · Medical/Dental Instruments · 4,846 employees
ATRC vs UFPT FAQ
Which is bigger, AtriCure or UFP Technologies?
AtriCure (ATRC) is larger, with a market capitalization of $2.80B compared with $2.25B for UFP Technologies (UFPT).
Which stock has performed better over the past year, ATRC or UFPT?
ATRC returned +50.63% over the past 12 months, compared with +45.90% for UFPT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ATRC or UFPT?
UFPT has the lower trailing P/E at 31.3, versus 262.0 for ATRC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are AtriCure and UFP Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.